Picture of Euroapi SA logo

EAPI Euroapi SA Share Price

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapValue Trap

Momentum

Relative Strength (%)
1m+6.61%
3m-56.47%
6m-51.63%
1yr-76.77%
Volume Change (%)
10d/3m-38.54%
Price vs... (%)
52w High-79.32%
50d MA-33.66%
200d MA-62.58%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-21.23%
Return on Equity-18.62%
Operating Margin-23%

Financial Summary

Year End 31st DecUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue€m915.8944.6892.8980.91,018.9946.6972.42.7%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%n/a+71.26-47.57+151.96+3437.84n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Euroapi SA EPS forecast chart

Profile Summary

Euroapi SAS is a France-based company. The Company is engaged in the development, manufacture and supply of active-ingredient solutions to its healthcare partners. It offers vitamin B12, prostaglandins, oligonucleotides, peptides, corticoids and hormones, anti-infectives, opiates (morphine, codeine, thebaine, etc.), analgesics, etc. The Company also provides technologies and develops molecules through it’s Contract Development and Manufacturing Organization (CDMO). It’s CDMO services include Tides, Prostaglandins, Particle Engineering, Microbial Fermentation, Small Molecules Synthesis, Steroids and Hormones and Opiates & Controlled Substances. It has production sites located in France, the United Kingdom, Germany, Italy and Hungary.

Directors

    Last Annual
    December 31st, 2023
    Last Interim
    December 31st, 2023
    Incorporated
    November 10th, 2020
    Public Since
    May 6th, 2022
    No. of Employees
    3,669
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    fr flag iconEuronext - Paris
    Shares in Issue
    94,838,094

    EAPI Share Price Performance

    Upcoming Events for EAPI

    Euroapi SAS Annual Shareholders Meeting

    Euroapi SA Annual Shareholders Meeting

    Euroapi SA Extraordinary Shareholders Meeting

    Similar to EAPI

    Picture of AB Science SA logo

    AB Science SA

    fr flag iconEuronext - Paris

    Picture of Advicenne SA logo

    Advicenne SA

    fr flag iconEuronext - Paris

    Picture of Aelis Farma SA logo

    Aelis Farma SA

    fr flag iconEuronext - Paris

    Picture of Boiron SA logo

    Boiron SA

    fr flag iconEuronext - Paris

    Picture of DBV Technologies SA logo

    DBV Technologies SA

    fr flag iconEuronext - Paris

    FAQ